Stefan Kasper
Researcher Next ID · RN-000157
Professor · Computer Science
Essen, Germany
- Works count
- 298
- Citation count
- 13,908
- H-index
- 38
- i10-index
- 89
About
297 publications and 13,905 citations recorded on OpenAlex.
Research interests
Publications
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
The Lancet · 2023 · 10.1016/s0140-6736(23)00772-9
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)32557-1
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Oral Oncology · 2018 · 10.1016/j.oraloncology.2018.04.008
Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial
The Lancet Oncology · 2017 · 10.1016/s1470-2045(17)30421-7
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine · 2016 · 10.1056/nejmoa1602252
Current projects
No projects listed.